FemBloc issued patent provides additional coverage for Femasys’ therapeutic option for women seeking permanent birth controlATLANTA, Nov. 01, 2024 (GLOBE...
- Completed strategic review to focus on oncology and severe liver diseases - Announced acquisition of global rights to BRM-1420,...
DENVER, Nov. 01, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary...
Bagsværd, Denmark, 1 November 2024 – Novo Nordisk today announced the headline results from part 1 of the ongoing ESSENCE...
Conference call to be held Monday, November 4, 2024, at 8:30 AM ETNEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) --...
BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights...
All funds are supporting breast cancer care at the McGill University Health Centre (MUHC) The MUHC Foundation and the Beat...
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a...
LUND, SE / ACCESSWIRE / November 01, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) invites investors, analysts and...
STOCKHOLM, SE / ACCESSWIRE / November 01, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group AB (publ.) presents today, November 1,...
San Diego Entrepreneur Highlights the Role of International Food Markets in Cultural Exchange and Community Building SAN DIEGO, CA /...